Showing 2951-2960 of 20417 results for "".
- Inebilizumab Significantly Reduces Disease Flares in Patients With IgG4-Related Diseasehttps://reachmd.com/news/inebilizumab-significantly-reduces-disease-flares-in-patients-with-igg4-related-disease/2468691/A groundbreaking phase 3 clinical trial led by Mass General Brigham has identified inebilizumab as a promising treatment for immunoglobulin G4-related disease (IgG4-RD), a rare but debilitating condition. Published in the New England Journal of Medicine, the study revealed that inebilizu
- Study Links Psoriasis Severity to Increased Heart Disease Riskhttps://reachmd.com/news/study-links-psoriasis-severity-increased-heart-disease-risk/2468660/Psoriasis severity is associated with increased cardiovascular risk, according to new research, with systemic inflammation functioning as a key mediator. Data from two cohorts—the Psoriasis Atherosclerosis and Cardiometabolic Disease Initiative (PACI) and the Stockholm Psoriasis Cohort (SP
- New Biomarker Identified to Predict IBD Treatment Responsehttps://reachmd.com/news/new-biomarker-identified-to-predict-ibd-treatment-response/2468655/Inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis, is treated with therapies such as vedolizumab, a monoclonal antibody that blocks integrin α4β7. By preventing specific immune cells from migrating into the gut, vedolizumab aims to reduce inflammation and promote
- Gastroenterology Education Improved Through Inpatient Care Teaching Modelhttps://reachmd.com/news/gastroenterology-education-improved-through-inpatient-care-teaching-model/2468656/Credit: CC0 Public Domain Gastroenterologists who focus primarily on providing inpatient care, called GI Hospitalists, are b
- Targeting the Heart: New Research Unveils Immune Drivers of Myocarditis in Cancer Therapyhttps://reachmd.com/news/targeting-the-heart-new-research-unveils-immune-drivers-of-myocarditis-in-cancer-therapy/2468616/Myocarditis, a rare but often fatal complication of immune checkpoint inhibitor (ICI) cancer therapies, has long puzzled clinicians and researchers. A new study led by the Broad Institute of MIT and Harvard and Massachusetts General Hospital (MGH) sheds light on the immune mechanisms behind this
- Cannabis Use and Psychotic-Like Experiences in Adolescents: Insights From Metabolomic Researchhttps://reachmd.com/news/cannabis-use-and-psychotic-like-experiences-in-adolescents-insights-from-metabolomic-research/2468644/A study from the University of Eastern Finland has uncovered how cannabis use influences the metabolomic profiles linked to psychotic-like experiences in adolescents. By analyzing blood samples from 76 teenagers experiencing depression, researchers identified distinct metabolomic changes in canna
- Fujirebio Submits FDA Regulatory Filing for Lumipulse® G pTau 217/β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test as an Aid to Identify Patients with Amyloid Pathology Associated with Alzheimer’s Diseasehttps://reachmd.com/news/fujirebio-submits-fda-regulatory-filing-for-lumipulse-g-ptau-217-amyloid-1-42-plasma-ratio-in-vitro-diagnostic-test-as-an-aid-to-identify-patients-with-amyloid-pathology-associated-with-alzheimers-disease/2468639/MALVERN, Pa. & TOKYO--(BUSINESS WIRE)--Fujirebio today announced that its wholly-owned subsidiary Fujirebio Diagnostics, Inc. has filed its Lumipulse® G pTau 217/β-
- PSC Without IBD Linked to Elevated Colorectal Cancer Risk, New Findings Showhttps://reachmd.com/news/psc-without-ibd-linked-to-elevated-colorectal-cancer-risk-new-findings-show/2468610/Primary sclerosing cholangitis (PSC), a chronic liver disease, has been associated with an elevated colorectal cancer (CRC) risk, particularly when combined with inflammatory bowel disease (IBD). However, new findings presented at the American College of Gastroenterology (ACG) 2024 An
- Patient-Initiated Telemedicine Follow-Up Reduces Healthcare Visits in Spondyloarthritis Managementhttps://reachmd.com/news/patient-initiated-telemedicine-follow-up-reduces-healthcare-visits-in-spondyloarthritis-management/2468624/A new study from the Netherlands reveals that a patient-initiated follow-up (PIFU) model, supported by asynchronous telemedicine, significantly reduces healthcare visits for individuals with stable spondyloarthritis. The TeleSpA study shows that PIFU, where patients initiate follow-up as needed,
- New Imaging Technique Could Advance Understanding of Psychiatric Disordershttps://reachmd.com/news/new-imaging-technique-could-advance-understanding-of-psychiatric-disorders/2468627/Researchers at Yokohama City University (YCU) have developed an imaging method that may enhance our understanding of psychiatric disorders by enabling scientists to visualize specific neuronal receptors involved in these conditions. This advancement may eventually lead to improved diagnostic tool